Donepezil Zentiva

Donepezil Zentiva is a prescription medication that contains the active ingredient Donepezil Hydrochloride. It is formulated for oral administration and is classified as an acetylcholinesterase inhibitor used in the management of Alzheimer’s disease. The product is marketed in the European Union and follows the standard regulatory requirements for prescription drugs.

Donepezil Zentiva is indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease. It may be prescribed to help improve cognitive function and daily living activities in patients diagnosed with this condition.

- Improves memory and attention in Alzheimer’s patients - Supports daily functional abilities - May be used as part of a comprehensive Alzheimer’s care plan - Typically prescribed after a clinical diagnosis of Alzheimer’s disease - May be combined with non‑pharmacologic therapies

Side effects of Donepezil Zentiva vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Nausea or vomiting - Diarrhea - Insomnia or abnormal dreams - Muscle cramps or weakness - Loss of appetite - Fatigue

Serious: - Severe bradycardia or heart block - Syncope (fainting) - Gastrointestinal bleeding - Hepatotoxicity (liver injury) - Seizures

Before starting Donepezil Zentiva, certain health considerations should be reviewed to ensure safe use.

- Assess cardiac history, especially bradyarrhythmias - Evaluate liver function in patients with hepatic disease - Use cautiously in patients with a history of seizures - Monitor for signs of gastrointestinal bleeding - Review concomitant medications that affect heart rate - Discuss pregnancy and breastfeeding status with a healthcare professional

Donepezil Zentiva can interact with several drug classes, requiring careful management.

Avoid: - Strong anticholinergic agents (e.g., diphenhydramine) - Certain antiarrhythmic drugs (e.g., quinidine) - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine)

Use with caution: - Beta‑blockers and other heart‑rate‑lowering medications - NSAIDs or anticoagulants (risk of GI bleeding) - Other cholinesterase inhibitors - Drugs that prolong QT interval